Serum Non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: The Third National Health and Nutrition Examination Survey linked mortality study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Li, Chaoyang ^a   Ford, Earl S ^a   Tsai, James ^b   Zhao, Guixiang ^a   Balluz, Lina S ^a   Gidding, Samuel S ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Lipids; Lipoproteins; Mortality

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; PHYSICAL ACTIVITY; RISK FACTOR; SMOKING HABIT; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED STATES; ADULT; BLOOD; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; DYSLIPIDEMIA; MIDDLE AGED; NUTRITION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; TIME; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DYSLIPIDEMIAS; HUMANS; LINEAR MODELS; MIDDLE AGED; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; UP-REGULATION; YOUNG ADULT;

EID: 79956218817     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-46     Document Type: Article

References (44)

1. Anonymous Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, Anonymous.
2. Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence. Cardiovasc Diabetol 2011, 10:20. 10.1186/1475-2840-10-20, 3056766, 21356116.
3. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001, 161:1413-1419. 10.1001/archinte.161.11.1413, 11386890.
4. Farwell WR, Sesso HD, Buring JE, Gaziano JM. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am J Cardiol 2005, 96:1129-1134. 10.1016/j.amjcard.2005.06.044, 16214451.
5. Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006, 98:1363-1368. 10.1016/j.amjcard.2006.06.032, 17134630.
6. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007, 298:776-785. 10.1001/jama.298.7.776, 17699011.
7. Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Ohta H. Association between non-high-density lipoprotein cholesterol concentrations and mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study. J Atheroscler Thromb 2010, 17:30-36.
8. Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004, 27:1991-1997. 10.2337/diacare.27.8.1991, 15277429.
9. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003, 26:16-23. 10.2337/diacare.26.1.16, 12502653.
10. Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005, 28:1916-1921. 10.2337/diacare.28.8.1916, 16043732.
11. Fox CS, Coady S, Sorlie PD, D'Agostino RB, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007, 115:1544-1550. 10.1161/CIRCULATIONAHA.106.658948, 17353438.
12. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
13. Laakso M, Lehto S, Penttila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993, 88:1421-1430.
14. Bruno G, Merletti F, Biggeri A, Bargero G, Prina-Cerai S, Pagano G, Cavallo-Perin P. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study. Diabetologia 2006, 49:937-944. 10.1007/s00125-006-0195-6, 16525840.
15. National Center for Health Statistics Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94 1994, 1-407. Series I: programs and collection procedures, National Center for Health Statistics.
16. Centers for Disease Control and Prevention The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) reference manuals and reports [CD-ROM] 1996, National Center for Health Statistics, Bethesda, MD, Centers for Disease Control and Prevention.
17. Gunter EW, Lewis SM, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 1996, USDHHS/PHS/CDC, Atlanta.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van LF, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. 2763564, 19414839.
20. Selvin E, Manzi J, Stevens LA, Van LF, Lacher DA, Levey AS, Coresh J. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 1994, 50:918-926.
21. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF, Paffenbarger RS. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993, 25:71-80. 10.1249/00005768-199301000-00011, 8292105.
22. Centers for Disease Control and Prevention NHANES 2005-2006. Accessed 2-19-2008., Centers for Disease Control and Prevention., http://www.cdc.gov/nchs/about/major/nhanes/nhanes2005-2006/nhanes05_06.htm
23. National Center for Health Statistics, Office of Analysis and Epidemiology The Third National Health and Nutrition Examination Survey (NHANES III) Linked Mortality File, mortality follow-up through 2006: Matching Methodology. Accessed 2009., National Center for Health Statistics, Office of Analysis and Epidemiology., http://www.cdc.gov/nchs/data/datalinkage/matching_methodology_nhanes3_final.pdf
24. Anderson RN, Minono AM, Hoyert DL. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001, 49:1-32.
25. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958.
26. Korn EL, Graubard BI. Analysis of health surveys 1999, 345-346. John Wiley & Sons, New York.
27. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009, 265:275-287. 10.1111/j.1365-2796.2008.02016.x, 19019184.
28. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007, 68:556-562. 10.1212/01.wnl.0000254472.41810.0d, 1805634, 17310025.
29. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006, 48:2235-2242. 10.1016/j.jacc.2006.09.030, 2442907, 17161253.
30. Canoui-Poitrine F, Luc G, Bard JM, Ferrieres J, Yarnell J, Arveiler D, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P, Empana JP. Relative Contribution of Lipids and Apolipoproteins to Incident Coronary Heart Disease and Ischemic Stroke: The PRIME Study. Cerebrovasc Dis 2010, 30:252-259. 10.1159/000319067, 20664258.
31. Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, Elkind MS. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol 2009, 66:1400-1406. 10.1001/archneurol.2009.210, 2830863, 19901173.
32. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis 2009, 203:587-592. 10.1016/j.atherosclerosis.2008.07.020, 18783774.
33. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006, 37:1663-1667. 10.1161/01.STR.0000226604.10877.fc, 16728686.
34. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke 1996, 27:210-215.
35. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338:1650-1656. 10.1056/NEJM199806043382302, 9614255.
36. McGill HC, McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 2008, 117:1216-1227. 10.1161/CIRCULATIONAHA.107.717033, 18316498.
37. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108:1664-1672. 10.1161/01.CIR.0000087480.94275.97, 14530185.
38. van der Worp HB, van GJ. Clinical practice. Acute ischemic stroke. N Engl J Med 2007, 357:572-579. 10.1056/NEJMcp072057, 17687132.
39. Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004, 27:1496-1504. 10.2337/diacare.27.6.1496, 15161808.
40. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, U.S. Department of Health and Human Services, Center for Disease Control and Prevention, Atlanta, GA, Centers for Disease Control and Prevention.
41. Haffner SM. Dyslipidemia management in adults with diabetes. Diabetes Care 2004, 27(Suppl 1):S68-S71.
42. runzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008, 51:1512-1524. 10.1016/j.jacc.2008.02.034, 18402913.
43. ardner CD, Winkleby MA, Fortmann SP. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). Am J Cardiol 2000, 86:299-304. 10.1016/S0002-9149(00)00918-8, 10922437.
44. Bowlin SJ, Morrill BD, Nafziger AN, Jenkins PL, Lewis C, Pearson TA. Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey. J Clin Epidemiol 1993, 46:561-571. 10.1016/0895-4356(93)90129-O, 8501483.